Report: Public-Private Partnerships for Global Health: How PATH Advances Technologies Through Cross-Sector Collaboration
PATH
March 2013; 8 pages
This policy report highlights the essential role that public-private partnerships play in driving global health product development and offers insights into the key components of successful multi-sector partnerships led by PATH.
http://www.path.org/publications/files/ER_app_ppp_policy_rpt.pdf

Excerpt
RECOMMENDATIONS
Adequately fund public-private partnerships to maximize global health impact
Public-private partnerships are an efficient and sustainable model for conducting global health research and development throughout the product lifecycle. They leverage the resources and expertise of different stakeholders to accelerate the development and delivery of high-impact, cost-effective products to improve public health. As the lead funder of global health research and development, the public sector should ensure that its investments support the critical work of public-private partnerships in accelerating the availability, accessibility, and affordability of global health technologies.

Provide support throughout the product lifecycle to accelerate innovation, introduction, and integration of global health technologies
To maximize impact, the public and private sectors and NGOs must begin with the end in mind. Support by the public sector for technology development alone does not guarantee that a product will reach those most in need. To ensure that innovative ideas become products that efficiently advance from development through wide-scale adoption for sustained public health impact, the public sector must support the products throughout their lifecycle. Thus, investment in market development from the very beginning is essential to build the foundation for supply, create demand, and provide an incentive for private-sector partners to sustain their investments.

Create incentives for private-sector engagement to advance health products for low-resource settings
Public-sector investment—through funding, capacity strengthening, or providing incentives—helps to create an enabling environment that encourages commercialinvestment in global health. Incentives such as accelerated regulatory reviews and pooled funding mechanisms enable commercial partners to meet the needs of the public and the private sectors. Such incentives need to be offered in combination with other innovative mechanisms—such as milestone prizes that provide rewards for incremental achievements along the product lifecycle—to ensure mutual benefits for the public and private sectors, as well as for the global health missions of NGOs like PATH.